Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MEGH.NS Stock Summary
In the News
MEGH.NS Financial details
Company Rating
Strong Buy
Market Cap
35.29B
Income
2.41B
Revenue
22.29B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.87K
Optionable
No
Shortable
Yes
Earnings
19 Oct 2023
P/E
14.72
Forward P/E
-
PEG
-7.02
P/S
410060387.18
P/B
2.92
P/C
-
P/FCF
-40.68
Quick Ratio
0.01
Current Ratio
1.21
Debt / Equity
-
LT Debt / Equity
0.38
-
-
EPS (TTM)
7.46
EPS next Y
-
EPS next Q
-
EPS this Y
0%
EPS next Y
-
EPS next 5Y
96.9%
EPS last 5Y
23.77%
Revenue last 5Y
10.05%
Revenue Q/Q
5.12%
EPS Q/Q
-14.42%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
9%
ROE
22%
ROC
0.21%
Gross Margin
40%
Oper. Margin
19%
Profit Margin
11%
Payout
18%
Shs Outstand
253.85M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
46.7-153.95
52W High
-9.15%
52W Low
+202.17%
RSI
-
Rel Volume
1.01
Avg Volume
5.43M
Volume
5.51M
Perf Week
0%
Perf Month
0%
Perf Quarter
0%
Perf Half Y
0%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
0%
Price
139
Change
4.32%
MEGH.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2020-03-31
Metric | History | 2016-03-31 | 2017-03-31 | 2018-03-31 | 2020-03-31 | 2020-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 53.32 | 60.83 | 70.75 | 86.05 | 86.05 | |
Net income per share | 3.25 | 3.45 | 6.74 | 9.44 | 9.44 | |
Operating cash flow per share | 7.89 | 10.18 | 15.92 | 15.9 | 15.9 | |
Free cash flow per share | 4.17 | 7.39 | 6.26 | -3.41 | -3.41 | |
Cash per share | 0.43 | 1.52 | 2.98 | -1.12 | 0.34 | |
Book value per share | 25.25 | 28.26 | 34.23 | 47.54 | 47.54 | |
Tangible book value per share | 29.4 | 33.61 | 41.19 | 52.21 | 52.21 | |
Share holders equity per share | 25.25 | 28.26 | 34.23 | 47.54 | 47.54 | |
Interest debt per share | 21.51 | 16.61 | 16.6 | 33.43 | 33.43 | |
Market cap | 5.77B | 9.47B | 22.8B | 9.42B | 9.42B | |
Enterprise value | 10.52B | 13.08B | 26.61B | 17.35B | 17.35B | |
P/E ratio | 6.99 | 10.8 | 13.31 | 3.92 | 3.92 | |
Price to sales ratio | 0.43 | 0.61 | 1.27 | 0.43 | 0.43 | |
POCF ratio | 2.88 | 3.66 | 5.63 | 2.33 | 2.33 | |
PFCF ratio | 5.44 | 5.04 | 14.31 | -10.86 | -10.86 | |
P/B Ratio | 0.9 | 1.32 | 2.62 | 0.78 | 0.78 | |
PTB ratio | 0.9 | 1.32 | 2.62 | 0.78 | 0.78 | |
EV to sales | 0.78 | 0.85 | 1.48 | 0.79 | 0.79 | |
Enterprise value over EBITDA | 4.08 | 4.87 | 6.82 | 3.49 | 3.49 | |
EV to operating cash flow | 5.24 | 5.05 | 6.57 | 4.29 | 4.29 | |
EV to free cash flow | 9.92 | 6.96 | 16.71 | -20 | -20 | |
Earnings yield | 0.14 | 0.09 | 0.08 | 0.25 | 0.25 | |
Free cash flow yield | 0.18 | 0.2 | 0.07 | -0.09 | -0.09 | |
Debt to equity | 0.76 | 0.52 | 0.44 | 0.66 | 0.66 | |
Debt to assets | 0.3 | 0.24 | 0.21 | 0.29 | 0.29 | |
Net debt to EBITDA | 1.84 | 1.34 | 0.98 | 1.6 | 1.6 | |
Current ratio | 1.32 | 1.39 | 1.85 | 1.21 | 1.21 | |
Interest coverage | 3.29 | 9.55 | 9.58 | 9.34 | 8.36 | |
Income quality | 2.43 | 2.95 | 2.36 | 1.13 | 1.13 | |
Dividend Yield | 0.01 | 0 | 0 | 0.04 | 0.04 | |
Payout ratio | 0.09 | 0 | 0.06 | 0.18 | 0.18 | |
Sales general and administrative to revenue | 0.02 | 0 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.47 | -0.27 | -0.61 | -1.21 | -1.21 | |
Capex to revenue | -0.07 | -0.05 | -0.14 | -0.22 | -0.22 | |
Capex to depreciation | -1.23 | -0.78 | -2.59 | -5.54 | -5.54 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 42.95 | 46.84 | 72.03 | 100.5 | 100.5 | |
ROIC | 0.13 | 0.33 | 0.2 | 0.18 | 0.16 | |
Return on tangible assets | 0.05 | 0.06 | 0.1 | 0.09 | 0.09 | |
Graham Net | -29.02 | -21.48 | -20.33 | -28.68 | -27.21 | |
Working capital | 1.91B | 2.14B | 3.87B | 1.71B | 1.71B | |
Tangible asset value | 7.48B | 8.54B | 10.48B | 13.28B | 13.28B | |
Net current asset value | -878.5M | 595.93M | 1.13B | -3.62B | -3.62B | |
Invested capital | 0.76 | 0.52 | 0.44 | 0.66 | 0.66 | |
Average receivables | 0 | 0 | 0 | 3.08B | 6.16B | |
Average payables | 1.62B | 1.72B | 1.79B | 2.35B | 2.75B | |
Average inventory | 2.3B | 2.43B | 2.55B | 3.1B | 3.52B | |
Days sales outstanding | 0 | 0 | 0 | 102.77 | 102.77 | |
Days payables outstanding | 71.92 | 75.15 | 73.53 | 76.96 | 76.96 | |
Days of inventory on hand | 97.75 | 111.11 | 100.93 | 98.5 | 98.5 | |
Receivables turnover | 0 | 0 | 0 | 3.55 | 3.55 | |
Payables turnover | 5.07 | 4.86 | 4.96 | 4.74 | 4.74 | |
Inventory turnover | 3.73 | 3.29 | 3.62 | 3.71 | 3.71 | |
ROE | 0.13 | 0.12 | 0.2 | 0.2 | 0.2 | |
Capex per share | -3.72 | -2.79 | -9.66 | -19.31 | -19.31 |
Quarterly Fundamentals Overview
Last date of statement is 2020-12-31 for Q4
Metric | History | 2019-12-31 | 2020-03-31 | 2020-06-30 | 2020-09-30 | 2020-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 20.51 | 0 | 16.84 | 24.59 | 25.89 | |
Net income per share | 1.87 | 0 | 1.54 | 3.19 | 2.73 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 6.69 | 0 | |
Book value per share | 0 | 0 | 0 | 52.21 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 58.61 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 52.21 | 0 | |
Interest debt per share | 0 | 0 | 0 | 26.52 | 0 | |
Market cap | 14.55B | 0 | 13.06B | 20.47B | 21B | |
Enterprise value | 0 | 7.93B | 0 | 26.47B | 0 | |
P/E ratio | 7.64 | 0 | 8.34 | 6.3 | 7.57 | |
Price to sales ratio | 2.79 | 0 | 3.05 | 3.27 | 3.19 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 1.54 | 0 | |
PTB ratio | 0 | 0 | 0 | 1.54 | 0 | |
EV to sales | 0 | 1.53 | 0 | 4.23 | 0 | |
Enterprise value over EBITDA | 0 | 6.78 | 0 | 15.21 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.03 | 0 | 0.03 | 0.04 | 0.03 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.66 | 0 | 0.5 | 0 | |
Debt to assets | 0 | 0.29 | 0 | 0.22 | 0 | |
Net debt to EBITDA | 0 | 6.78 | 0 | 3.45 | 0 | |
Current ratio | 0 | 1.21 | 0 | 1.3 | 0 | |
Interest coverage | 6.69 | 4.32 | 7.41 | 12.25 | 5.53 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.03 | 0 | 0.02 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 61.22 | 0 | |
ROIC | 0 | 0.04 | 0 | 0.05 | 0 | |
Return on tangible assets | 0 | 0.02 | 0 | 0.03 | 0 | |
Graham Net | 0 | 0 | 0 | -27.13 | 0 | |
Working capital | 0 | 1.71B | 0 | 2.47B | 0 | |
Tangible asset value | 0 | 13.28B | 0 | 14.91B | 0 | |
Net current asset value | 0 | -3.62B | 0 | -3.36B | 0 | |
Invested capital | 0 | 0.66 | 0 | 0.5 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 107.15 | 0 | 68.99 | 0 | |
Days payables outstanding | 0 | 66.29 | 0 | 85.9 | 0 | |
Days of inventory on hand | 0 | 84.84 | 0 | 116.93 | 0 | |
Receivables turnover | 0 | 0.84 | 0 | 1.3 | 0 | |
Payables turnover | 0 | 1.36 | 0 | 1.05 | 0 | |
Inventory turnover | 0 | 1.06 | 0 | 0.77 | 0 | |
ROE | 0 | 0.04 | 0 | 0.06 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
MEGH.NS Frequently Asked Questions
What is Meghmani Organics Limited stock symbol ?
Meghmani Organics Limited is a IN stock , located in Ahmedabad of Gujarat and trading under the symbol MEGH.NS
What is Meghmani Organics Limited stock quote today ?
Meghmani Organics Limited stock price is $139 today.
Is Meghmani Organics Limited stock public?
Yes, Meghmani Organics Limited is a publicly traded company.